Baiqiang Cai
Overview
Explore the profile of Baiqiang Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lian H, Kou L, Han X, Rui Z, Dong S, Zhang X, et al.
BMC Pulm Med
. 2024 Oct;
24(1):487.
PMID: 39367367
Background: Exacerbation of chronic obstructive pulmonary disease (ECOPD) results in severe adverse outcomes and mortality. It is often associated with increased local and systemic inflammation. However, individual susceptibility to exacerbations...
2.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al.
Ther Adv Respir Dis
. 2023 Jun;
17:17534666231178692.
PMID: 37318116
Background: Chronic obstructive pulmonary disease (COPD) management in China is far from adequate; underdiagnosis and undertreatment are major barriers to optimal care and improved patient outcomes. Objective: To generate reliable...
3.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al.
Ther Adv Respir Dis
. 2023 Apr;
17:17534666231167353.
PMID: 37073797
Background: Chronic obstructive pulmonary disease (COPD) management in China is inadequate and there is a need to improve care and outcomes for patients nationwide. Objectives: The REAL study was designed...
4.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al.
Ther Adv Respir Dis
. 2023 Apr;
17:17534666231158283.
PMID: 37013442
Background: Underdiagnosis and undertreatment pose major barriers to optimal management of chronic obstructive pulmonary disease (COPD) in China. Objective: The REAL trial was performed to generate reliable information on real-world...
5.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al.
Respir Res
. 2022 Jun;
23(1):159.
PMID: 35717186
No abstract available.
6.
Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, et al.
Respir Res
. 2022 Apr;
23(1):106.
PMID: 35488337
Background: Chronic obstructive pulmonary disease (COPD) receives low awareness and is undertreated in China. Understanding the burden and treatment of COPD across the nation is important for improving quality of...
7.
Kang J, Zheng J, Cai B, Wen F, Yao W, Zhang X, et al.
Ther Adv Respir Dis
. 2020 Oct;
14:1753466620961699.
PMID: 33103591
Background And Aims: Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) is poorly recognized in China. Our study determined the distribution of ACO and its clinical characteristics among patients (aged ⩾40 ...
8.
Peng M, Meng H, Sun Y, Xiao Y, Zhang H, Lv K, et al.
J Thorac Dis
. 2020 Feb;
11(12):5042-5052.
PMID: 32030220
Background: Pulmonary mucormycosis (PM) is a relatively rare but often fatal and rapidly progressive disease. Most studies of PM are case reports or case series with limited numbers of patients,...
9.
Yang T, Cai B, Cao B, Kang J, Wen F, Yao W, et al.
BMC Pulm Med
. 2020 Jan;
20(1):11.
PMID: 31931767
Background: Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death in China with a reported prevalence of 8.2% people aged ≥40 years. It is recommended that Chinese...
10.
Liang Y, Chen Y, Wu R, Lu M, Yao W, Kang J, et al.
J Thorac Dis
. 2018 Jan;
9(12):5120-5130.
PMID: 29312718
Background: Chronic bronchitis (CB) is closely associated with the frequency and severity of chronic obstructive pulmonary disease (COPD) exacerbation. However, little is known about the impact of CB on COPD...